BioSpace News Archive

- ApiJect Systems, Corp., a global injectable platform technology company that revolutionizes how medicines and vaccines are filled, finished, and delivered, announced today that James A. Garrett has joined the organization as its new General Counsel and Chief Compliance Officer. This appointment took effect December 7, 2020 .

Strategic Leadership Comes as Awareness and Momentum Around Pancreatic Cancer is Increasing Following a Succesful Pancreatic Cancer Awareness Month in November

The investigational vaccine is the first-of-its-kind for type 1 diabetes to be tested in the United States and showed positive results in an early study in Europe

Children’s Health Defense (CHD) is raising significant concerns based on the briefing released for the FDA’s Vaccines and Related Biological Products Advisory Committee meeting scheduled Thursday, December 10th, to review the Pfizer coronavirus vaccine BNT162b2.

Enzolytics, Inc. announced the filing of a provisional patent with the U.S. Patent Office on December 9, 2020 for a treatment of Multiple Sclerosis developed by Harry Zhabilov, titled NUCLEAR PROTEINS ISOLATED FROM MAMALIAN SPINAL CORD IMMUNE FACTOR, Ser. No. 62/123341.

Sunovion Pharmaceuticals Inc. (Sunovion) today announced that new data and analyses of late-stage compounds SEP-363856 and SEP-4199 were presented at the 59th Annual Meeting of the American College of Neuropsychopharmacology virtual meeting, which took place December 6-9.

LCGC™, a leading multimedia platform of peer-reviewed technical information on the field of chromatography and the separation sciences is pleased to announce that Paul Haddad and Erik L. Regalado are the winners of the 14th Annual LCGC™ Lifetime Achievement and Emerging Leader in Chromatography Awards

Bioasis Technologies Inc. is pleased to announce that all resolutions were passed by requisite majority at its annual general meeting held earlier in New Haven, Conn., United States.

Sonoma Pharmaceuticals, Inc. (Nasdaq: SNOA), a global healthcare leader developing and producing high performance stabilized hypochlorous acid (HOCl) products for a wide range of applications, including wound care, eye care, oral care, nasal care and dermatological conditions, and Crown Laboratories, Inc., a fully integrated global skin care company, announce they have entered into a license and supply agreement for the e

American Bio Medica Corporation announced it has entered into a purchase agreement and registration rights agreement with Lincoln Park Capital Fund, LLC, a Chicago-based institutional investor.